Physician profile
Mark Ralph Ryser
NPI 1942321518
$3,056.22
in general payments reported to CMS, 2019-2025
7 companies · $479 in 2025
The $479 reported for 2025 was more than what 77% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.44 · 2020: $205 · 2021: $293 · 2022: $859 · 2023: $557 · 2024: $612 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Gift: $283 · Education: $136 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.40 |
| Gift | $283.13 |
| Education | $135.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,333.58 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $279.76 | 2024-2025 | Biomaterials, Geistlich Bio-Gide |
| Keystone Dental INC. | $135.62 | 2023 | |
| Dentsply Sirona INC | $94.34 | 2022 | |
| Kerr Corporation | $84.17 | 2022 | |
| Southern Implants North America INC | $72.04 | 2020-2022 | |
| Nobel Biocare USA | $56.71 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ryser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.